EFECTIVIDAD DE LA TOXINA BOTULÍNICA TIPO A EN EL MANEJO DE LA CADERA ESPÁSTICA DE NIÑOS CON PARÁLISIS CEREBRAL / EFFECTIVENESS OF THE TOXIN BOTULINUM TYPE A IN THE DRIVING OF THE HIP CHILDREN'S SPASTICS WITH CEREBRAL PALSY

La espasticidad es uno de los principales factores de riesgo que predispone a la luxación de cadera en los niños con parálisis cerebral (PC). La aplicación de toxina botulínica (BTX A) en los músculos aductores de caderas reduce este riesgo

Spasticity is one of the main risk factors predisposing to hip dislocation in children with cerebral palsy (CP), Botulinum toxin A (BTX A) injection in hip adductor muscles reduces this risk

Predictor of fluid responsiveness in the 'grey zone': augmented pulse pressure variation through a temporary increase in tidal volume.

BACKGROUND: Pulse pressure variation (PPV) is widely used as a predictor of fluid responsiveness. However, a previous study has suggested a 'grey zone' between 9 and 13% in which PPV would be inconclusive to predict fluid responsiveness. Considering PPV is based on cardiopulmonary interactions, we evaluated whether an augmented PPV using a temporary increase in tidal volume (V T ) from 8 to 12 ml kg -1 has the predictability for fluid responsiveness in patients within the grey zone. METHODS: Adult patients requiring general anaesthesia were enrolled. During the period when PPV was within the range of 9-13%, haemodynamic variables such as stroke volume index (SVI) and PPV with an 8 ml kg -1 tidal volume ventilation (PPV8) were obtained before and after volume expansion (6 ml kg -1 ) under mechanical ventilation. Augmented PPV induced by 2-min ventilation with a V T of 12 ml kg -1 (PPV12) was also recorded immediately before volume loading. The patients whose SVI increased ≥10% after volume expansion were considered responders. RESULTS: In 38 enrolled patients, 20 were responders. Receiver operating characteristic curve analysis showed PPV12 had an excellent predictability for fluid responsiveness {area under the curve [AUC]=0.935 [95% confidence interval (CI) 0.805-0.989]; sensitivity 95%; specificity 72%; P <0.0001}. The optimal threshold for PPV12 was >17%. However, PPV8 failed to show significant predictability [AUC=0.668 (95% CI 0.497-0.812); sensitivity 65%; specificity 61%; P =0.06]. CONCLUSION: In mechanically ventilated patients, our augmented PPV successfully predicted fluid responsiveness in the previously suggested grey zone. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT02653469.